Atlas Trials

A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)

Clinical trial NCT02009878 · COMPLETED

Trial details

NCT number
NCT02009878
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
Start date
2013-11-01
Primary completion
2015-06-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.